LobbyingAkebia Therapeutics lobbying by quarter
Akebia Therapeutics AKBA's latest lobbying report covers Q2 2026, at $480K. The four quarters Q3 2025–Q2 2026 total $1.8M. Its first report covers Q4 2021; the issues it reports most are Health Issues and Medicare/Medicaid.
Akebia TherapeuticsAKBA
- Latest quarter
- $480K
- Q2 2026 · 3 reports
- Last 12 months
- $1.8M
- Last 4 quarters
- vs last quarter
- −17.9%
- Q2 2026 against the quarter before
- First report
- Q4 2021
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2021 | $60K | 1 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $370K | 2 |
| Q1 2023 | $360K | 2 |
| Q2 2023 | $360K | 2 |
| Q3 2023 | $290K | 2 |
| Q4 2023 | $280K | 2 |
| Q1 2024 | $420K | 2 |
| Q2 2024 | $310K | 2 |
| Q3 2024 | $330K | 2 |
| Q4 2024 | $320K | 3 |
| Q1 2025 | $395K | 3 |
| Q2 2025 | $555K | 3 |
| Q3 2025 | $375K | 3 |
| Q4 2025 | $355K | 3 |
| Q1 2026 | $585K | 3 |
| Q2 2026 | $480K | 3 |
Policy issues the reports name
- Health issues38 reports
- Medicare and Medicaid22 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES38 reports
- SENATE38 reports
- Centers For Medicare and Medicaid Services (CMS)20 reports
- Health & Human Services, Dept of (HHS)16 reports
- Office of Management & Budget (OMB)3 reports
- Office of Policy Development3 reports
- Government Accountability Office (GAO)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAkebia Therapeutics | $4.7M | 15 quarters |
| BGR Government Affairs | $840K | 16 quarters |
| The Petrizzo Group | $315K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q2 2026 |
| CHARLIE CHAPMAN | Policy Advisor, HHS; Special Asst, HHS; Prof Staff Member, House Budget Committee; LA, House Budget Committee; Staff Asst, House Ways and Means Committee; Intern, House Ways and Means Committee | Q2 2026 |
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q2 2026 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q2 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q2 2026 |
| RAGHAV AGGARWAL | Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q2 2026 |
| ROBERT WOOD | Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug | Q2 2026 |
| MEGAN CRISTINA PEREZ BURKE | Health Policy and Legislative Director to Chair McMorris Rodgers | Q4 2025 |
| ANDREW J LEWIN | Leg Asst/Dir., Rep. Dennis Moore; Leg Asst/Dir., Rep. Max Sandlin; Intern, House Min. Leader Richard Gephardt | Q4 2024 |
| JOHN STONE | See prior filing | Q1 2023 |
| CACHAVIOUS ENGLISH | See prior filing | Q4 2021 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $360K |
| 07/20for Q2 | BGR Government Affairs | $60K |
| 07/13for Q2 | The Petrizzo Group | $60K |
| 04/20for Q1 | In-house | $480K |
| 04/20for Q1 | BGR Government Affairs | $60K |
| 04/05for Q1 | The Petrizzo Group | $45K |
| 01/20for Q4 2025 | In-house | $260K |
| 01/20for Q4 2025 | BGR Government Affairs | $50K |
| 25/12/31for Q4 2025 | The Petrizzo Group | $45K |
| 25/10/20for Q3 2025 | In-house | $280K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $50K |
| 25/10/14for Q3 2025 | The Petrizzo Group | $45K |
| 25/07/21for Q2 2025 | In-house | $460K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $50K |
| 25/07/11for Q2 2025 | The Petrizzo Group | $45K |
| 25/04/21for Q1 2025 | In-house | $300K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $50K |
| 25/04/16for Q1 2025 | The Petrizzo Group | $45K |
| 25/01/21for Q4 2024 | In-house | $240K |
| 25/01/20for Q4 2024 | BGR Government Affairs | $50K |